In a recent paper, Fonseca, et al., sought out to describe the interaction between ORF10 and ZYG11B and determine whether it promotes the spread of SARS-CoV-2...
2022
T cell lineage fate is driven by CD4 and CD8 co-receptor gene loci
Shinzawa and colleagues aimed to identify whether the fate of thymocyte lineage is determined by coreceptor gene loci that regulate TCR signal duration, or by coreceptor proteins, which determine TCR signal strength.
Novel insights: immunotherapy responses in lung cancer
In a recent paper, de Miguel-Perez, et al., have described, validated and tested a blood test that, for the first time, can be used as a liquid biopsy to predict a patient’s response to cancer immunotherapy and whether it will be successful or not...
Comparing four COVID-19 vaccines
In a new study, researchers have investigated the level of induction of immunity from four different types of COVID-19 vaccines. They looked at how T-cells, B-cells, antibody levels change over six months following vaccination...
Does the timing of granuloma formation affect TB control?
In a recent paper, Gideon and colleagues demonstrate to us how diverse TB granulomas can be, not just between individuals, but within an individual...
ATLAS – describing SARS-CoV-2 variant T-cell responses
In a recent paper, Foti, et al., aimed to characterise the T-cell antigen response in response to SARS-CoV-2 variants using the ATLAS screening assay...
Human M1 macrophages champion the control of TB disease
In a recent paper, researchers have investigated the role of M1 macrophages in combating TB infection...
Cannabidiol – a potential tool for fighting SARS-CoV-2
In a new study, Fernandes, et al., aimed to determine the function of ORF8 and ORF10 genes and SARS-CoV-2 Membrane (M) protein and there effect on apoptosis...
Improving Chagas disease diagnosis and treatment
Researchers from Sweden have described the variant formation of Trypanosoma cruzi which are capable of evading the immune system and causing disease...
Bifonazole – a potential treatment for SARS-CoV-2 infection
In a recent paper by Taha, et al., the researchers identified the imidazole-based antifungal, Bifonazole, and characterised its activity against SARS-CoV-2 using high-throughput screening techniques...